Chemical Structure : Selumetinib
CAS No.: 606143-52-6
货号: PC-45849Not For Human Use, Lab Use Only.
Selumetinib (ARRY-142886, AZD-6244) highly potent and selective, ATP-uncompetitive inhibitor of MEK1/2 with IC50/Ki of 14.1 nM/22.6 nM for MEK1.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
50 mg | ¥580 | In stock | |
100 mg | ¥880 | In stock | |
250 mg | ¥1380 | In stock | |
1 g | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Selumetinib (ARRY-142886, AZD6244) highly potent and selective, ATP-uncompetitive inhibitor of MEK1/2 with IC50/Ki of 14.1 nM/22.6 nM for MEK1.
Selumetinib (ARRY-142886, AZD-6244) shows no activity against other 40 serine/threonine and tyrosine kinases.
Selumetinib (ARRY-142886, AZD-6244) inhibits cellular ERK1/2 phosphorylation (IC50<40 nM), suppresses growth inhibition of several cell lines containing B-Raf and Ras mutations (IC50=59-473 nM).
Selumetinib (ARRY-142886, AZD-6244) causes growth of HT-29 xenograft tumors in nude mice.
分子量 | 457.6814 | |
分子式 | C17H15BrClFN4O3 | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
DMSO: ≥ 34 mg/mL |
|
Chemical Name/SMILES |
1H-Benzimidazole-6-carboxamide, 5-[(4-bromo-2-chlorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl- |
1. Huynh H, et al. Mol Cancer Ther. 2007 Jan;6(1):138-46.
2. Yeh TC, et al. Clin Cancer Res. 2007 Mar 1;13(5):1576-83.
3. Davies BR, et al. Mol Cancer Ther. 2007 Aug;6(8):2209-19.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright